Pharmalot... Pharmalittle... Good Morning

Good morning, folks, and how are you today? We are just fine, thank you, although running a little behind schedule as we cope with assorted short people and their continued transition to the school year. This may become a perennial challenge. In any event, there is work to do. So please join us as we grab a cup of stimulation and attack the lengthening to-do list. And as always, here are some tidbits to get you started. Have a grand day and let us know if you hear something fascinating... Quadrivalent Flu Vaccines Offer A Promise Of Greater Profits (Reuters) BioMarin Stock Climbs On Speculation Of A Roche Bid (Bloomberg News) Drugmakers Remain Confused About FDA Breakthrough Designation (RPM Report) California Considers Bill To Curb Opioid Painkiller Abuse (The Los Angeles Times) Indian Regulator Says Ranbaxy Drugs In India Are Safe (The Hindu Business Line) Novartis Relaunched Neuroscience Research With Stanford Hire (The Boston Globe) NIH Awards $45M For Drug To Treat Alzheimer's Prevention (The New York Times) ...Read more
Source: Pharmalot - Category: Pharma Commentators Authors: Source Type: blogs